Fosun International LTD Abbott Laboratories Transaction History

Fosun International LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $1.83 Million - $2.21 Million	-17,900 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $353,462 - $431,024	3,100 Added 20.95%	17,900 $2.16 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $465,585 - $570,083	-4,030 Reduced 21.4%	14,800 $2.09 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $1.14 Million - $1.26 Million	-9,790 Reduced 34.21%	18,830 $2.25 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $258,127 - $303,853	-2,440 Reduced 7.86%	28,620 $3.36 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $582,838 - $686,671	-5,355 Reduced 14.71%	31,060 $3.72 Million
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $94,500 - $102,978	900 Added 2.53%	36,415 $3.95 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $108,593 - $131,878	1,185 Added 3.45%	35,515 $3.74 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $31,776 - $40,670	415 Added 1.22%	34,330 $3.06 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $79,153 - $115,743	1,260 Added 3.86%	33,915 $2.69 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $685,392 - $763,002	8,730 Added 36.49%	32,655 $2.85 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $434,364 - $506,600	-5,960 Reduced 19.94%	23,925 $2 Million
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $824,744 - $934,316	-12,580 Reduced 29.62%	29,885 $2.11 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $2.58 Million - $3.12 Million	42,465 New	42,465 $3.1 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.